Skip to content

Propess Versus Prostin for Induction of Labour in Women With Term PROM

Labour Induction With the Propess Vaginal Delivery System vs. Labour Induction With the Prostin Vaginal Tablet in Case of a Prelabour Rupture of Membranes. PESTIBOR Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04743297
Acronym
PESTIBOR
Enrollment
526
Registered
2021-02-08
Start date
2021-03-31
Completion date
2023-01-31
Last updated
2021-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of Labour, Premature Rupture of Membranes at Term

Keywords

Induction, PROM, Propess, Prostin

Brief summary

Premature rupture of membranes (PROM) at term is a rupture that occurs at term (\> 37 weeks) before the start of labor. The purpose of the study was to compare the safety and efficacy of two agents used in induction of labor in women with term PROM Propess (Controlled release dinoprostone, Vaginal Delivery System) and Prostin E2 (Dinoprostone vaginal Tablet). Women will be randomised to two treatment groups. Although some studies support efficacy of the Propess for cervical ripening at term in induction of labor with intact membranes, it has not been well studied in women with PROM at term.

Detailed description

The study is going to include all pregnant women with in-term PROM (after week 37 of pregnancy) without contractions if they meet the inclusion criteria. If the cervix is still non-inducible after 4-6 hours and there are no contractions, the medication to be administered to them will be determined by means of computer randomization. The success rate of induction with Propess vs. Prostin tablets will be compared. Soon after PROM, there can be the onset of contractions and cervix dilation that lead to childbirth. In case of some pregnant women, there are no contractions and cervix dilation even after the event despite PROM and water breaking. If the status remains unchanged, the risk of intrauterine infection, fetus infection, and later on an infection of the newborn increases. The expecting mother can also eventually lose hope for a successful vaginal birth and starts thinking about having a caesarean delivery. To avoid that, the investigators use medications that accelerate the onset of vaginal birth in clinical practice. The investigators know several ways to induce labour after PROM. References give no clear and reliable data on the best approach. The investigators can use medications such as oxytocin, dinoprostone, or misoprostol. Our ward has been using Prostin 3 mg (dinoprostone) vaginal tablets to induce labour in case of PROM for several years. They have proven to be an efficient and safe procedure in our clinical practice. Propess is used for the induction of labor with intact membranes. Based on the information from references and according to our experience, the medication is highly effective and safe, as well as easy to use. Our study aims at establishing whether it can also be used with pregnant women with PROM.

Interventions

DRUGProstaglandin E2 (Propess)

Propess - The vaginal insert is removed 24 h after the application. It is only to be removed earlier in case of the onset of active labour or at the occurrence of hyperstimulation.

DRUGProstaglandin E2 (Prostin)

Prostin - 3 mg vaginal tablet is placed in the posterior vaginal fornix. Dose can be repeated every 8 hours till onset of active labour or the occurrence of hyper-stimulation.

Sponsors

University Medical Centre Maribor
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 years or older * Gestational age 37 weeks or more * Singleton pregnancy * Cephalic presentation * Unfavorable cervix (BISHOP \<6) * No contraindications for vaginal delivery * Without uterine surgery * Without chorioamnionitis

Exclusion criteria

* Age less than 18 years * Multiple gestation * Previous cesarean section * Suspected intraamniotic infection * Any contraindication to vaginal delivery * Bishop score \>7 * Pathological ctg

Design outcomes

Primary

MeasureTime frame
Induction to Delivery Interval24 hours
Induction to Onset of labor Interval24 hours

Secondary

MeasureTime frame
Frequency of Cesarean Sections24 hours
Frequency of Failed Induction24 hours

Contacts

Primary ContactVeronika Anzeljc
veronika.anzeljc@ukc-mb.si+ 386 2 321 21 73
Backup ContactFaris Mujezinović
faris.mujezinovic@ukc-mb.si+ 386 2 321 24 08

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026